NCT02717208View on ClinicalTrials.gov

Phase 1 Study for Safety and Tolerability of HL036

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Dry Eye
Interventions
BIOLOGICAL

HL036

BIOLOGICAL

Vehicle

Trial Locations (1)

110-744

Seoul National University Hospital,Clinical Trial Center/ Clinical Research Institute, Seoul

Sponsors
All Listed Sponsors
lead

HanAll BioPharma Co., Ltd.

INDUSTRY

NCT02717208 - Phase 1 Study for Safety and Tolerability of HL036 | Biotech Hunter | Biotech Hunter